These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9949860)

  • 1. Peptide drug delivery into the central nervous system.
    Prokai L
    Prog Drug Res; 1998; 51():95-131. PubMed ID: 9949860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vector-mediated drug delivery to the brain.
    Temsamani J; Rousselle C; Rees AR; Scherrmann JM
    Expert Opin Biol Ther; 2001 Sep; 1(5):773-82. PubMed ID: 11728213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
    Johnson MD; Chen J; Anderson BD
    Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in drug delivery to the central nervous system by the prodrug approach.
    Pavan B; Dalpiaz A; Ciliberti N; Biondi C; Manfredini S; Vertuani S
    Molecules; 2008 May; 13(5):1035-65. PubMed ID: 18560328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches for drug delivery to central nervous system.
    Hossain S; Akaike T; Chowdhury EH
    Curr Drug Deliv; 2010 Dec; 7(5):389-97. PubMed ID: 20950269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery across the blood-brain barrier.
    Chen Y; Dalwadi G; Benson HA
    Curr Drug Deliv; 2004 Oct; 1(4):361-76. PubMed ID: 16305398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and transport of peptides and peptide drugs into the brain.
    Egleton RD; Davis TP
    Peptides; 1997; 18(9):1431-9. PubMed ID: 9392847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for delivering peptides into the central nervous system by sequential metabolism.
    Bodor N; Prokai L; Wu WM; Farag H; Jonalagadda S; Kawamura M; Simpkins J
    Science; 1992 Sep; 257(5077):1698-700. PubMed ID: 1529356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and circumventing the blood-brain barrier.
    Begley DJ
    Acta Paediatr Suppl; 2003 Dec; 92(443):83-91. PubMed ID: 14989470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier.
    Minn A; Leclerc S; Heydel JM; Minn AL; Denizcot C; Cattarelli M; Netter P; Gradinaru D
    J Drug Target; 2002 Jun; 10(4):285-96. PubMed ID: 12164377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier and treatment of central nervous system tumors.
    Wiranowska M
    J Fla Med Assoc; 1992 Oct; 79(10):707-10. PubMed ID: 1460453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug approaches for CNS delivery.
    Rautio J; Laine K; Gynther M; Savolainen J
    AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Ligands Deliver Model Drug Cargo into the Central Nervous System along Autonomic Neurons.
    Sellers DL; Tan JY; Pineda JMB; Peeler DJ; Porubsky VL; Olden BR; Salipante SJ; Pun SH
    ACS Nano; 2019 Oct; 13(10):10961-10971. PubMed ID: 31589023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS drug delivery: opioid peptides and the blood-brain barrier.
    Witt KA; Davis TP
    AAPS J; 2006 Feb; 8(1):E76-88. PubMed ID: 16584136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CNS as a target for peptides and peptide-based drugs.
    Banks WA
    Expert Opin Drug Deliv; 2006 Nov; 3(6):707-12. PubMed ID: 17076593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.